Persaud, Deryck R., and Alma Barranco-Mendoza. “Linking Chronic Infection and Autoimmune Diseases: Mycobacterium Avium Subspecies Paratuberculosis, SLC11A1 Polymorphisms and Type-1 Diabetes Mellitus.” PLOS ONE 4, no. Paccagnini, Daniela, Lee Sieswerda, Valentina Rosu, Speranza Masala, Adolfo Pacifico, Maria Gazouli, John Ikonomopoulos, Niyaz Ahmed, Stefania Zanetti, and Leonardo A. “Incidence of Insulin-Dependent Diabetes Mellitus in Age Groups over 30 Years in Denmark.” Diabetic Medicine: A Journal of the British Diabetic Association 11, no. “A Practical Review of C-Peptide Testing in Diabetes.” Diabetes Therapy 8, no. Leighton, Emma, Christopher AR Sainsbury, and Gregory C. “Diagnosis and Classification of Diabetes Mellitus.” Diabetes Care 33, no. “Diabetes in America, 3rd Edition | NIDDK.”. National Institute of Diabetes and Digestive and Kidney Diseases. “How Immunotherapy Could Stop and Prevent Type 1 Diabetes.”, March 3, 2020. The references in this article are listed below.Ītkinson, Mark A, George S Eisenbarth, and Aaron W Michels. We do our best to avoid using non evidence-based references in all articles. We rely on peer-reviewed studies, academic research institutions, governmental organizations, and reputable medical organizations. The present article analyses the role of private sector in health and suggests some policy guidelines and mechanisms for optimal utilization of private sector in health.Mastering Diabetes has strict guidelines for scientific references in our articles. Since the responsibility of health lies jointly with the public and the private sector, an optimal public-private mix would be the best solution for the country. It has been estimated that about 57 per cent of the hospitals and 32 per cent of total hospital beds are in the private sector. The private sector in India has emerged to play a significant role in the health care delivery system. Privatization, globalization and liberalization have become an important part of the political agenda in many countries. Simultaneously many developing countries are facing the burden of old unresolved problems and newly emerging challenges. The key concerns have been equity, efficiency and effectiveness. The study concluded that combination therapy is more effective in reducing neuropathic symptoms and pain in the lower limb than pharmacological intervention alone.ĭuring the recent years, countries all over the world at all levels of development are engaged in a creative search to find out better ways of organising and financing health care. The mean posttest lower limb pain score of combination therapy group (3.08) was lesser than the mean posttest lower limb pain score of pharmacological intervention group(4.27).(t(96)=11.91,p<0.001. The findings of the study revealed that the mean posttest neuropathic symptom score of combination therapy group (25.61) was lesser than the mean posttest neuropathic symptom scores of pharmacological intervention group (64.98).(t(96)=46.5,p<0.001. The present study has been undertaken to evaluate the effectiveness of two different modalities of treatment in reducing neuropathic symptoms and pain in the lower limbs among patients with diabetic peripheral neuropathy. It poses a significant risk factor for ulcer and non traumatic amputation. Diabetic peripheral neuropathy is a complication of long term diabetes and is characterized by diminished sensation and or pain in the lower extremities.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |